X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (90150) 90150
Newsletter (29281) 29281
Book Review (16528) 16528
Publication (8098) 8098
Newspaper Article (3572) 3572
Magazine Article (800) 800
Conference Proceeding (538) 538
Book Chapter (440) 440
Trade Publication Article (186) 186
Transcript (151) 151
Book / eBook (141) 141
Web Resource (79) 79
Dissertation (56) 56
Government Document (37) 37
Streaming Video (31) 31
Data Set (17) 17
Reference (15) 15
Report (9) 9
Paper (7) 7
Journal / eJournal (6) 6
Presentation (2) 2
Video Recording (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (70231) 70231
humans (67308) 67308
antiviral agents (65028) 65028
antiviral agents - therapeutic use (36878) 36878
female (29648) 29648
male (29613) 29613
hiv (25373) 25373
adult (22873) 22873
health aspects (20226) 20226
research (20137) 20137
middle aged (19866) 19866
drug therapy (17988) 17988
aids (14289) 14289
infectious diseases (14068) 14068
highly active antiretroviral therapy (13721) 13721
animals (13476) 13476
infection (13171) 13171
virology (13071) 13071
care and treatment (12786) 12786
treatment outcome (12371) 12371
antiviral agents - pharmacology (11872) 11872
medical research (11429) 11429
hepatitis c virus (11093) 11093
analysis (10981) 10981
hepatitis c (10951) 10951
medicine, experimental (10219) 10219
hiv infections - drug therapy (10172) 10172
gastroenterology & hepatology (10126) 10126
hepatitis c, chronic - drug therapy (10036) 10036
virus diseases (9903) 9903
immunology (9845) 9845
drug therapy, combination (9820) 9820
pharmacology & pharmacy (9732) 9732
hiv infection (9730) 9730
antiviral agents - administration & dosage (9565) 9565
therapy (9029) 9029
aged (8856) 8856
anti-hiv agents (8799) 8799
viruses (8669) 8669
interferon (8033) 8033
microbiology (8025) 8025
risk factors (7486) 7486
human immunodeficiency virus--hiv (7447) 7447
interferon-alpha - therapeutic use (7363) 7363
infections (7295) 7295
hepatitis b (6924) 6924
antiviral agents - adverse effects (6756) 6756
hepatitis (6752) 6752
viral load (6584) 6584
hiv patients (6558) 6558
abridged index medicus (6498) 6498
ribavirin - therapeutic use (6349) 6349
adolescent (6281) 6281
universities and colleges (5910) 5910
ribavirin (5866) 5866
genotype (5855) 5855
aids/hiv (5782) 5782
drugs (5717) 5717
antiretroviral therapy (5641) 5641
hepacivirus - genetics (5466) 5466
hepatitis c - drug therapy (5360) 5360
mice (5319) 5319
antiviral therapy (5160) 5160
prevention (4946) 4946
dosage and administration (4927) 4927
young adult (4886) 4886
retrospective studies (4815) 4815
recombinant proteins (4715) 4715
reports (4624) 4624
drug resistance (4622) 4622
hepatitis b, chronic - drug therapy (4613) 4613
liver (4521) 4521
medicine, general & internal (4517) 4517
time factors (4480) 4480
influenza (4449) 4449
medicine (4432) 4432
virus replication - drug effects (4425) 4425
research article (4380) 4380
transplantation (4374) 4374
child (4363) 4363
hepatitis b virus (4306) 4306
virus-infection (4246) 4246
antiretroviral drugs (4131) 4131
replication (4120) 4120
mortality (4114) 4114
hepacivirus - drug effects (3988) 3988
human-immunodeficiency-virus (3965) 3965
rna (3958) 3958
biological response modifiers (3878) 3878
disease (3865) 3865
human immunodeficiency virus (3839) 3839
anti-hiv agents - therapeutic use (3789) 3789
article (3780) 3780
usage (3768) 3768
pharmaceutical industry (3740) 3740
genetic aspects (3675) 3675
patients (3664) 3664
hiv infections - complications (3600) 3600
multidisciplinary sciences (3598) 3598
cell line (3596) 3596
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (87) 87
Online Resources - Online (77) 77
Collection Dvlpm't (Acquisitions) - Vendor file (9) 9
Collection Dvlpm't (Acquisitions) - Closed Orders (7) 7
UofT at Mississauga - Stacks (6) 6
UofT at Scarborough - Stacks (4) 4
Gerstein Science - Periodical Stacks (3) 3
Gerstein Science - Bindery (2) 2
Credit Valley Hospital - Stacks (1) 1
Earth Sciences (Noranda) - Stacks (1) 1
Media Commons - Audio Visual (1) 1
New College (Ivey) - Stacks (1) 1
Providence Healthcare - Stacks (1) 1
Scarborough Hospital - Hospital Department (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Toronto East General Hospital - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (117542) 117542
French (1231) 1231
German (962) 962
Chinese (943) 943
Spanish (916) 916
Russian (812) 812
Japanese (709) 709
Korean (319) 319
Polish (269) 269
Italian (201) 201
Hungarian (128) 128
Dutch (107) 107
Portuguese (78) 78
Danish (70) 70
Swedish (51) 51
Romanian (50) 50
Czech (48) 48
Croatian (42) 42
Turkish (36) 36
Finnish (29) 29
Serbian (25) 25
Ukrainian (25) 25
Norwegian (24) 24
Hebrew (23) 23
Bulgarian (15) 15
Slovak (9) 9
Lithuanian (4) 4
Bosnian (3) 3
Icelandic (2) 2
Afrikaans (1) 1
Albanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2001, ISBN 9781555811563, x, 359
Book
by El-Sadr, W.M and Grund, B and Neaton, J.D and Neuhaus, J and Cohen, C.J and Darbyshire, J and Babiker, A and Emery, S and Lundgren, J.D and Phillips, A and Jensen, K.B and Gey, D.C and Borup, L and Pearson, M and Jansson, P.O and Jensen, B.G and Tverland, J and Juncker-Benzon, H and Fox, Z and Phillips, A.N and Babiker, A.G and Palfreeman, A.J and Fleck, S.L and Dodds, W and King, E and Cordwell, B and van Hooff, F and Collaco-Moraes, Y and Angus, B.J and Cooper, D.A and Drummond, F.M and Connor, S.A and Satchell, C.S and Gunn, S and Oka, S and Delfino, M.A and Merlin, K and McGinley, C and Gordin, F and Finley, E and Dietz, D and Chesson, C and Vjecha, M and Standridge, B and Bartsch, G and Duchene, A and George, M and Harrison, M and Krum, E and Larson, G and Miller, C and Nelson, R and Roediger, M.P and Schultz, T and Prineas, R and Campbell, C and Zhang, Z.M and Perez, G and Lifson, A and Duprez, D and Hoy, J and Lahart, C and Perlman, D and Price, R and Rhame, F and Sampson, J and Worley, J and Rein, M and Dersimonian, R and Brody, B.A and Daar, E.S and Dubler, N.N and Fleming, T.R and Freeman, D.J and Kahn, J.P and Kim, K.M and Medoff, G and Modlin, J.F and Moellering, R and Murray, B.E and Pick, B and Robb, M.L and Scharfstein, D.O and Sugarman, J and Tsiatis, A and Tuazon, C and Zoloth, L and Klingman, K and Lehrman, S and Lazovski, J and Belloso, W.H and Losso, M.H and Benetucci, J.A and Aquilia, S and Bittar, V and Bogdanowicz, E.P and Cahn, P.E and Casiró, A.D and Cassetti, I and Contarelli, J.M and ... and SMART Study Grp and SMART Study Group and The SMART Study Group
Annals of Internal Medicine, ISSN 0003-4819, 09/2008, Volume 149, Issue 5, pp. 289 - 299
Journal Article
Lancet, The, ISSN 0140-6736, 2013, Volume 382, Issue 9904, pp. 1555 - 1563
Journal Article
1998, ISBN 0387915109, xi, 161
Book
Clinical Infectious Diseases, ISSN 1058-4838, 6/2011, Volume 52, Issue 11, pp. 1374 - 1383
Background. The optimal time to initiate antiretroviral therapy (ART) in human immunodeficiency virus (HIV)—associated tuberculous meningitis is unknown.... 
Statistical median | HIV/AIDS | Antiretrovirals | Art therapy | Meningeal tuberculosis | HIV | Mortality | Random allocation | AIDS | Arts | HIV 1 | MORTALITY | SURVIVAL | THAILAND | INFECTIOUS DISEASES | HIV-INFECTION | ERA | ADOLESCENTS | CLINICAL-TRIALS | ADULTS | RISK | MICROBIOLOGY | IMMUNOLOGY | Lamivudine - administration & dosage | Humans | Antiretroviral Therapy, Highly Active - adverse effects | Male | Zidovudine - administration & dosage | Anti-HIV Agents - administration & dosage | Time Factors | Adult | Anti-Inflammatory Agents - administration & dosage | Female | HIV Infections - mortality | Antiretroviral Therapy, Highly Active - methods | Tuberculosis, Meningeal - mortality | Placebos - administration & dosage | Dexamethasone - administration & dosage | Tuberculosis, Meningeal - drug therapy | Benzoxazines - administration & dosage | Double-Blind Method | Trimethoprim, Sulfamethoxazole Drug Combination - administration & dosage | Anti-HIV Agents - adverse effects | Treatment Outcome | Tuberculosis, Meningeal - complications | HIV Infections - complications | Antitubercular Agents - administration & dosage | HIV Infections - drug therapy | Antiviral agents | Care and treatment | Patient outcomes | Dosage and administration | Drug therapy | Health aspects | HIV infection | Comorbid patients | Tuberculous meningitis | Clinical trials | Antiretroviral drugs | Meningitis | Human immunodeficiency virus--HIV | Risk assessment | Medical treatment | Index Medicus
Journal Article
Annals of Internal Medicine, ISSN 0003-4819, 11/2016, Volume 165, Issue 9, pp. 625 - 634
Journal Article
Annals of Internal Medicine, ISSN 0003-4819, 07/2013, Volume 159, Issue 2, pp. 86 - 96
Background: Telaprevir (TVR) plus peginterferon-alpha 2a (PEG-IFN-alpha 2a) and ribavirin substantially increases treatment efficacy for genotype 1 chronic... 
Vertex pharmaceuticals and janssen pharmaceuticals | MEDICINE, GENERAL & INTERNAL | COINFECTED PATIENTS | MANAGEMENT | RECOMMENDATIONS | PREDICTORS | BOCEPREVIR | HCV | UPDATE | VIROLOGICAL RESPONSE | ASSOCIATION | INTERFERON PLUS RIBAVIRIN | HIV-1 | Recombinant Proteins - therapeutic use | Antiviral Agents - pharmacokinetics | Humans | Middle Aged | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Polyethylene Glycols - adverse effects | Male | Recombinant Proteins - pharmacokinetics | Recombinant Proteins - adverse effects | Oligopeptides - adverse effects | Polyethylene Glycols - therapeutic use | Oligopeptides - therapeutic use | Ribavirin - pharmacokinetics | Interferon-alpha - pharmacokinetics | Adult | Anti-HIV Agents - therapeutic use | Female | Drug Therapy, Combination | Double-Blind Method | Antiviral Agents - therapeutic use | Oligopeptides - pharmacokinetics | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | Polyethylene Glycols - pharmacokinetics | Genotype | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Ribavirin - adverse effects | Antiviral Agents - adverse effects | HIV Infections - complications | Interferon-alpha - adverse effects | Antiviral agents | Patient outcomes | Dosage and administration | Drug therapy, Combination | Research | Hepatitis C | Drug therapy | HIV infection | Drugs | Clinical trials | Hepatitis | Side effects | Human immunodeficiency virus--HIV | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Hepatology, ISSN 0168-8278, 2013, Volume 59, Issue 3, pp. 434 - 441
Journal Article
Journal of Infectious Diseases, ISSN 0022-1899, 2015, Volume 211, Issue 5, pp. 744 - 754
Journal Article